近15~20年间,气道炎症在哮喘病中的重要性越来越引起重视,这种炎症似乎是引起哮喘病特有症状的原因,因而哮喘的各种治疗方案都将其炎症作为主攻方向。治疗哮喘病的药物虽然很多,但不外乎两大类。一类属于缓解剂,这类药物包括各种支气管扩张剂,而以β受体激动剂为代表;另一类属 In the recent 15 to 20 years, the importance of airway inflammation in asthma has drawn increasing attention. This inflammation appears to be the cause of the specific symptoms of asthma. Therefore, various treatments of asthma have its inflammation as the main direction. Although a lot of drugs to treat asthma, but nothing more than two categories. One belongs to the group of relievers, which include various bronchodilators and are represented by beta-agonists; the other is